Dosage ; See below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Diziron | Glenmark | Harley's Limited | 25mg | 20 | Tablet | per tablet | KES 332 |
| Diziron | Glenmark | Harley's Limited | 25mg | Tablet | per tablet | KES 332 | |
| Stugeron | Janssen Cilag | Laborex Kenya Eurapharma Ltd | 25mg | 50 | Tablet | per tablet | KES 522.00 |
| Stugeron | Janssen Cilag | Laborex Kenya Eurapharma Ltd | 75mg | 20 | Capsule | per capsule | KES 450.00 |
| Stugeron | Janssen Cilag | Laborex Kenya Eurapharma Ltd | 25mg | 50 | Tablet | per tablet | KES 522.00 |
| Stugeron | Janssen Cilag | Laborex Kenya Eurapharma Ltd | 75mg | 20 | Capsule | per capsule | KES 450.00 |
| Vertigon | Beta Healthcare International Ltd | Beta Healthcare International Ltd | 25mg | 100 | Tablet | per tablet | KES 585.00 |
| Cinnarizine More info | |
|---|---|
| Drug Indication | Peripheral vascular disease, Raynauds syndrome; Vestibular disorders; Motion sickness |
| Precautions | Severe heart failure. |
| Side Effects | Drowsiness, occasional dry mouth, blurred vision, allergic reactions. |
| Dosage | Peripheral vascular disease, Raynauds syndrome: 75mg TID initially. Maintenance: 75mg BD or TID. Vestibular disorders: 25mg TID. Children: 5-12 years 15mg TID. Motion sickness: 25mg, 2 hours before travel then 15mg TID during the journey. Children: Half adult dose. |
| Special Information | Peripheral vasodilator and antihistamine for treatment of vestibular disorders. |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Peripheral vasodilators |